Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 20, 2003

View Archived Issues

R&D highlights from the Rodman & Renshaw Techvest Healthcare Conference: Biomira

R&D highlights from the Rodman & Renshaw Techvest Healthcare Conference: Cel-Sci

R&D highlights from the Rodman & Renshaw Techvest Healthcare Conference: BioSante

Pivotal trial commences for Acapodene in advanced prostate cancer

Series B financing supports clinical development programs at Saegis

New bradykinin B2 modulators and their use reported by Ortho-McNeil

Roche claims new c-Met kinase inhibitors and their use in cancer therapy

Novel glucocorticoid receptor modulators covered by Merck patent

Celltech researchers describe new IMPDH inhibitors in a recent patent

Astex prepares and tests new series of p38 MAP kinase inhibitors

Novel antiangiogenic agents revealed in recent Abbott patent

Indian investigators report COX inhibitors for pain, fever and inflammation

Antibacterial steroids designed by Leo Pharma scientists

Novel GH secretagogues, their preparation and use, claimed by Lilly

IND filed for phase I/II trial of AME-527 for rheumatoid arthritis

Advair Diskus receives FDA approval

Genome Therapeutics and GeneSoft to merge

GPI-1485 enters phase II trial for postprostatectomy erectile dysfunction

Icatibant awarded orphan drug status for angioedema

Approvable letter for Topamax in the prophylaxis of migraine

Positive preliminary results for safinamide in phase II epilepsy study

Vfend approved for esophageal candidiasis

New analysis of data from TNF-alpha AutoVac trial shows antibody levels

NDA submitted for ezetimibe/simvastatin

L-type calcium channel blocker with strong visceral antinociceptive effects

Improvement in cognitive performance seen in sleep-deprived primates treated with Ampakine compound

Potent, selective, nonpeptide MCH1 receptor antagonist with anorexic activity

Transgene discusses findings on new agents for gene therapy at European meeting

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 12, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...